Vigil Neuroscience, Inc. (VIGL)
NASDAQ: VIGL · Real-Time Price · USD
1.790
0.00 (0.00%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Vigil Neuroscience Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Vigil Neuroscience stock have an average target of 16.33, with a low estimate of 13 and a high estimate of 22. The average target predicts an increase of 812.29% from the current stock price of 1.79.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 14, 2025.
Analyst Ratings
The average analyst rating for Vigil Neuroscience stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Maintains $24 → $13 | Buy | Maintains | $24 → $13 | +626.26% | Mar 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $17 → $14 | Strong Buy | Maintains | $17 → $14 | +682.12% | Mar 14, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Jan 24, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $17 | Strong Buy | Reiterates | $17 | +849.72% | Jan 23, 2025 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Dec 4, 2024 |
Financial Forecast
Revenue This Year
n/a
from 315.20M
Revenue Next Year
n/a
EPS This Year
-2.02
from -2.07
EPS Next Year
-1.70
from -2.02
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | 73.8M | 183.8M | ||
| Avg | n/a | 23.9M | 82.8M | ||
| Low | n/a | n/a | 18.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | 669.3% | ||
| Avg | - | - | 246.6% | ||
| Low | - | - | -24.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.73 | -0.92 | -0.56 | ||
| Avg | -2.02 | -1.70 | -1.81 | ||
| Low | -2.26 | -2.08 | -2.51 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.